PMID: 16634335Apr 26, 2006Paper

Increased morbidity and mortality in acute human organophosphate-poisoned patients treated by oximes: a meta-analysis of clinical trials

Human & Experimental Toxicology
Roja RahimiMohammad Abdollahi

Abstract

Organophosphates are one of the most common causes of poisoning, especially in the Third world, with high morbidity and mortality. The treatment of this type of poisoning involves the use of atropine and oximes. Atropine has been used successfully in large doses to counteract the muscarinic effects of organophosphate poisoning, but the efficacy of oximes in the management of this poisoning remains under question. In this study, we undertook a meta-analysis by reviewing all clinical trials to evaluate the efficacy of oximes in the management of organophosphate poisoning. The databases of PUBMED, EMBASE, Cochrane, SCOPUS, and the search engine of Google were searched for all clinical trials on the use of oximes in organophosphate poisoning. The inclusion criteria were death, development of intermediate syndrome, and need for ventilation. Six clinical trials met the inclusion criteria and were included in the metaanalysis. The chi2 tests for heterogeneity (P = 0.25, 0.16, and 0.33, respectively) indicated that the included studies were not significantly heterogeneous and could be combined. A significant relative risk (P = 0.0017) for death among oxime-exposed was 2.17 (95% CI of 1.34-3.51). The 'need for ventilation' in patients w...Continue Reading

References

Apr 1, 1971·The American Journal of Medicine·T NambaD Grob
Oct 1, 1996·Archives of Environmental Contamination and Toxicology·S Sánchez-FortúnM V Barahona
Jan 1, 1997·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·Y NishiuraM Ando
Apr 1, 1997·The Annals of Pharmacotherapy·G M Tush, M I Anstead
Jan 1, 1997·Journal of Toxicology. Clinical Toxicology·M AbdollahiT Ghanea
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Aug 21, 2001·Critical Care : the Official Journal of the Critical Care Forum·M Sungur, M Güven
Jan 24, 2002·Therapeutic Drug Monitoring·Tai C Kwong
Feb 9, 2002·BMJ : British Medical Journal·Demetrius EvisonPaul Rice
Apr 30, 2002·QJM : Monthly Journal of the Association of Physicians·M EddlestonN Buckley
Jun 6, 2003·Pharmacology & Toxicology·Jirí Kassa, Gabriela Krejèová
Jul 1, 1961·The Journal of Pharmacy and Pharmacology·D M SANDERSON
Feb 27, 2004·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Mohammad AbdollahiShahin Shadnia
Jul 17, 2004·Seminars in Neurology·Daniel E Rusyniak, Kristine A Nañagas
Nov 20, 2004·Journal of Applied Toxicology : JAT·Georg A PetroianuWolfgang H Maleck
Feb 4, 2005·Human & Experimental Toxicology·Abdolkarim PajoumandMohammad Abdollahi
Jul 1, 2005·Environmental Toxicology and Pharmacology·Akram RanjbarMohammad Abdollahi

❮ Previous
Next ❯

Citations

Aug 21, 2007·Lancet·Michael EddlestonAndrew H Dawson
Jan 29, 2013·Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences·Mohammd MoshiriMahdi Balali-Mood
Jan 16, 2009·Internal Medicine·Cemil KavalciGülsüm Kavalci
Jun 30, 2009·Journal of Emergencies, Trauma, and Shock·Praveen Aggarwal, Nayer Jamshed
Oct 16, 2013·Expert Opinion on Drug Discovery·Paul Wilhelm ElsinghorstTimo Wille
Jan 3, 2016·Neurotoxicology·Amr Mohamed Tawfik KhattabAlaa AbdelHamid Mekdad
Sep 26, 2009·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Florian EyerHorst Thiermann
Oct 7, 2010·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·Kishore PichamuthuJohn Victor Peter
Mar 31, 2007·The Kaohsiung Journal of Medical Sciences·Tzeng-Jih LinHong-Ping Li
Oct 5, 2013·The American Journal of Emergency Medicine·Nicholas J ConnorsRobert S Hoffman
May 18, 2013·The American Journal of Emergency Medicine·Xue TangWenbiao Zhao
Jan 5, 2011·Toxicology Letters·Zdeněk FišarKamil Kuča
Nov 26, 2009·The American Journal of Emergency Medicine·Hsien-Yi ChenChih-Chuan Lin
May 8, 2007·Emergency Medicine Clinics of North America·David T Lawrence, Mark A Kirk
Jul 16, 2009·Journal of Applied Toxicology : JAT·D E Lorke, G A Petroianu
Apr 22, 2010·Basic & Clinical Pharmacology & Toxicology·Alessandra Antunes dos SantosMarcelo Farina
Jul 31, 2007·Expert Opinion on Pharmacotherapy·John Victor PeterPetra L Graham
May 6, 2015·Comparative Biochemistry and Physiology. Toxicology & Pharmacology : CBP·Gabriela Rodríguez-FuentesDaniel Schlenk
Jul 16, 2016·Journal of Toxicology·Naofumi BunyaSteven B Bird
May 25, 2013·Human & Experimental Toxicology·S Karami-MohajeriM Abdollahi
Jul 28, 2016·Annals of the New York Academy of Sciences·Doodipala Samba Reddy
Oct 21, 2016·Archives of Toxicology·Shokoufeh HassaniMohammad Abdollahi
Nov 7, 2007·Human & Experimental Toxicology·Shahin ShadniaMohammad Abdollahi
Dec 13, 2017·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Adam BlumenbergSage W Wiener
Jun 7, 2013·Arhiv za higijenu rada i toksikologiju·Syed M NurulainSyed N H Naqvi
Apr 3, 2014·Iranian Red Crescent Medical Journal·Sara MostafalouMohammad Abdollahi
Jul 21, 2020·Toxicological Research·B Shrikar ReddyGirish Thunga
Jun 9, 2020·Archives of Toxicology·Franz WorekTimo Wille
Jun 19, 2021·Toxicology Research·Ashok Kumar PannuRajesh Vijayvergiya
Jan 14, 2020·Toxicology and Applied Pharmacology·Igor Simões Assunção FelippeKarla Nívea Sampaio

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.